Eli Lilly receives marketing authorisation for baricitinib
4th October 2022 Uncategorised 0Treatment involves adult patients with severe alopecia areata
More: Eli Lilly receives marketing authorisation for baricitinib
Source: News
Treatment involves adult patients with severe alopecia areata
More: Eli Lilly receives marketing authorisation for baricitinib
Source: News
© 1994 - 2026 B.M. Pharmaceuticals